This HTML5 document contains 127 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n8http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q51343799
rdf:type
wikibase:Item
schema:description
artikulong pang-agham tieteellinen artikkeli 2012年学术文章 სამეცნიერო სტატია wetenschappelijk artikel vitskapeleg artikkel bài báo khoa học 2012年学术文章 scientific article published on 15 July 2012 2012年學術文章 artikel ilmiah artigo científico vedecký článok 2012年學術文章 vetenskaplig artikel article científic article scientific naučni članak 2012年の論文 artikull shkencor научни чланак 2012年学术文章 научная статья 2012年学术文章 artykuł naukowy 2012년 논문 2012年學術文章 2012年学术文章 bilimsel makale 2012年學術文章 artigo científico articolo scientifico ১৫ জুলাই ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article published on 15 July 2012 научни чланак επιστημονικό άρθρο scienca artikolo 2012 nî lūn-bûn บทความทางวิทยาศาสตร์ artículo científico publicado en 2012 videnskabelig artikel מאמר מדעי مقالة علمية نشرت في 15 يوليو 2012 vědecký článek научна статия 2012年学术文章 наукова стаття, опублікована в липні 2012 article scientifique teaduslik artikkel vitenskapelig artikkel artículu científicu artigo científico 2012年學術文章 articol științific мақолаи илмӣ scientific article published on 15 July 2012 wissenschaftlicher Artikel tudományos cikk
p:P577
wds:Q51343799-4133377F-6972-480C-A431-822BE7FE6BBA
wdt:P577
2012-07-15T00:00:00Z
p:P2888
wds:Q51343799-1F5C5335-F321-4C63-B84E-5D8ACDA902E4
wdt:P2888
n12:s00408-012-9408-6
p:P2860
wds:Q51343799-3B9A690C-9CB7-43A5-99F5-BACF7563BA40 wds:Q51343799-26F922F4-B18E-440F-B413-5F64F7615E19 wds:Q51343799-6C1D7D77-2770-4A8C-9AD5-45ECD8F9337F wds:Q51343799-920B5540-10DE-4484-AA05-E2469AF46C57 wds:Q51343799-5745F21F-2F51-444E-8D2A-B8792123CA13 wds:Q51343799-59E522EA-F46A-4904-8617-369C39C6375D wds:Q51343799-BF503750-2C06-4266-8867-5926E579E5F6 wds:Q51343799-CA32627E-6B51-4A3B-BD1A-B13B53F9752C wds:Q51343799-E794A02F-70C7-4D30-AA9A-416C0982B5EA wds:Q51343799-964DD9F4-7EBB-41C5-89B6-6CA1F98F34F3 wds:Q51343799-A3EC1E2A-A21A-4D70-AF02-BD7BCB4BB824 wds:Q51343799-F8B9462E-A644-4633-AC5A-08AF07E2410C wds:Q51343799-FA3FC3B3-C164-474A-ABEB-9062304828B7 wds:Q51343799-0390B0C4-01C6-4FA2-97C3-034B7C111330
wdt:P2860
wd:Q45332746 wd:Q53246607 wd:Q46694356 wd:Q37791040 wd:Q54062676 wd:Q45215345 wd:Q59554796 wd:Q34562650 wd:Q48737494 wd:Q51912699 wd:Q45089480 wd:Q37097714 wd:Q80332624 wd:Q36939543
p:P2093
wds:Q51343799-0EC4CD59-E59F-4C9B-8066-A598B222144F wds:Q51343799-16AA8E98-2353-4F8E-8750-E2CC2A7CDA86 wds:Q51343799-F05BEAC8-3950-4D8D-9D38-B687B5823219 wds:Q51343799-33C59519-38B7-4CE3-A33B-5AF4DB4EB6AE wds:Q51343799-657F754F-5033-49FE-9016-7EA3B97D7485 wds:Q51343799-9642B5DC-2FA4-4679-A384-B2238500FBCA
wdt:P2093
Nargues Weir Merte Lemma Oksana A Shlobin A Whitney Brown Shahzad Ahmad Steven D Nathan
rdfs:label
Transition of PH patients from sildenafil to tadalafil: feasibility and practical considerations. Transition of PH patients from sildenafil to tadalafil: feasibility and practical considerations.
skos:prefLabel
Transition of PH patients from sildenafil to tadalafil: feasibility and practical considerations. Transition of PH patients from sildenafil to tadalafil: feasibility and practical considerations.
schema:name
Transition of PH patients from sildenafil to tadalafil: feasibility and practical considerations. Transition of PH patients from sildenafil to tadalafil: feasibility and practical considerations.
p:P1476
wds:Q51343799-54C61122-82FB-4C47-BD22-2C757D115B89
wdt:P1476
Transition of PH patients from sildenafil to tadalafil: feasibility and practical considerations.
p:P304
wds:Q51343799-33D00BCE-52B3-44F1-A5BD-ABBA944E2769
wdt:P304
573-578
p:P31
wds:Q51343799-CFCD40BB-1414-4F33-B7BD-52B19F0C6B81
wdt:P31
wd:Q13442814
p:P698
wds:Q51343799-1FE87BC2-777E-4F51-B39D-4ED910CCA69F
wdtn:P698
n9:22797830
wdt:P698
22797830
p:P1433
wds:Q51343799-BE804231-561F-4CD2-A78B-2E23989CB93C
wdt:P1433
wd:Q15765075
p:P433
wds:Q51343799-5D2FEE3D-119D-4EF1-842B-1E577F8378AF
p:P478
wds:Q51343799-794AF016-B0DF-4D15-A6A9-14D23B6BDFBB
wdt:P433
5
wdt:P478
190
p:P356
wds:Q51343799-B47C6DD3-CD2D-4B37-96EB-B900BC7D34F2
wdtn:P356
n8:S00408-012-9408-6
wdt:P356
10.1007/S00408-012-9408-6